329 related articles for article (PubMed ID: 26581022)
1. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
2. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
3. Accounting for prompt gamma emission and detection for range verification in proton therapy treatment planning.
Tian L; Huang Z; Janssens G; Landry G; Dedes G; Kamp F; Belka C; Pinto M; Parodi K
Phys Med Biol; 2021 Feb; 66(5):055005. PubMed ID: 33171445
[TBL] [Abstract][Full Text] [Related]
4. Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification.
Polf JC; Avery S; Mackin DS; Beddar S
Phys Med Biol; 2015 Sep; 60(18):7085-99. PubMed ID: 26317610
[TBL] [Abstract][Full Text] [Related]
5. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
6. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
7. Correlations between the shifts in prompt gamma emission profiles and the changes in daily target coverage during simulated pencil beam scanning proton therapy.
Lens E; Jagt TZ; Hoogeman MS; Schaart DR
Phys Med Biol; 2019 Apr; 64(8):085009. PubMed ID: 30921771
[TBL] [Abstract][Full Text] [Related]
8. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.
Moteabbed M; España S; Paganetti H
Phys Med Biol; 2011 Feb; 56(4):1063-82. PubMed ID: 21263174
[TBL] [Abstract][Full Text] [Related]
10. Detecting prompt gamma emission during proton therapy: the effects of detector size and distance from the patient.
Polf JC; Mackin D; Lee E; Avery S; Beddar S
Phys Med Biol; 2014 May; 59(9):2325-40. PubMed ID: 24732052
[TBL] [Abstract][Full Text] [Related]
11. Prompt gamma ray imaging for verification of proton boron fusion therapy: A Monte Carlo study.
Shin HB; Yoon DK; Jung JY; Kim MS; Suh TS
Phys Med; 2016 Oct; 32(10):1271-1275. PubMed ID: 27229367
[TBL] [Abstract][Full Text] [Related]
12. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
[TBL] [Abstract][Full Text] [Related]
13. 3D prompt gamma imaging for proton beam range verification.
Draeger E; Mackin D; Peterson S; Chen H; Avery S; Beddar S; Polf JC
Phys Med Biol; 2018 Jan; 63(3):035019. PubMed ID: 29380750
[TBL] [Abstract][Full Text] [Related]
14. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
[TBL] [Abstract][Full Text] [Related]
15. The use of non-standard CT conversion ramps for Monte Carlo verification of 6 MV prostate IMRT plans.
Zarza-Moreno M; Cardoso I; Teixeira N; Jesus AP; Mora G
Phys Med; 2013 Jun; 29(4):357-67. PubMed ID: 22677401
[TBL] [Abstract][Full Text] [Related]
16. Requirements for a Compton camera for in vivo range verification of proton therapy.
Rohling H; Priegnitz M; Schoene S; Schumann A; Enghardt W; Hueso-González F; Pausch G; Fiedler F
Phys Med Biol; 2017 Apr; 62(7):2795-2811. PubMed ID: 28195562
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of post treatment positron emission tomography/computed tomography to detect inter-fractional range variations in scanned ion beam therapy.
Handrack J; Tessonnier T; Chen W; Liebl J; Debus J; Bauer J; Parodi K
Acta Oncol; 2017 Nov; 56(11):1451-1458. PubMed ID: 28918686
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
19. Classification of the source of treatment deviation in proton therapy using prompt-gamma imaging information.
Khamfongkhruea C; Berthold J; Janssens G; Petzoldt J; Smeets J; Pausch G; Richter C
Med Phys; 2020 Oct; 47(10):5102-5111. PubMed ID: 32678913
[TBL] [Abstract][Full Text] [Related]
20. Time-of-flight neutron rejection to improve prompt gamma imaging for proton range verification: a simulation study.
Biegun AK; Seravalli E; Lopes PC; Rinaldi I; Pinto M; Oxley DC; Dendooven P; Verhaegen F; Parodi K; Crespo P; Schaart DR
Phys Med Biol; 2012 Oct; 57(20):6429-44. PubMed ID: 22996154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
